{"id":10,"date":"2018-11-29T12:39:12","date_gmt":"2018-11-29T12:39:12","guid":{"rendered":"https:\/\/alivamab.com\/dev\/?page_id=10"},"modified":"2022-07-08T15:43:27","modified_gmt":"2022-07-08T22:43:27","slug":"company","status":"publish","type":"page","link":"https:\/\/alivamab.com\/dev\/company\/","title":{"rendered":"Company"},"content":{"rendered":"<h1>Company<\/h1>\n<h2 id=\"about\">About Us<\/h2>\n<p>AlivaMab Discovery Services (ADS) sets its partners\u2019 antibody discovery programs on the fastest and most de-risked path through discovery and development. Trusted by top-tier pharmaceutical and biotechnology companies, ADS delivers drug-quality, fully human antibodies on exceptional timelines. ADS achieves its partners\u2019 design goals, from simple to extraordinarily challenging, through the generation and function-first screening of large, molecularly diverse panels of antibodies. ADS focuses on rapid and efficient delivery of antibodies, characterized for function, kinetics and developability, and engineering for advanced modalities, including multispecifics and CARs. The ADS team\u2019s experience in antibody drug discovery and development comes from many of the world\u2019s top 15 pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer and Roche\/Genentech, and translates across more than 500 discovery programs and 35 clinical candidates. This experience, combined with the use of trusted, proven technologies, including Ablexis\u2019 AlivaMab\u00ae Mouse platforms, ensures the highest probability of success.<\/p>\n<p><strong>Mission<\/strong><\/p>\n<p>To empower our partners with the fastest and most de-risked path through therapeutic antibody discovery and development.<\/p>\n<p><strong>Vision<\/strong><\/p>\n<p>A healthier world through partnerships that bring better medicines to patients faster.<\/p>\n<h2 id=\"contact-us\">Contact<\/h2>\n<p>AlivaMab Discovery Services, LLC<br \/>\n<u><\/u><u><\/u>10581 Roselle Street, Suite 115<br \/>\nSan Diego, CA 92121<br \/>\n1-858-866-9310<br \/>\n<a href=\"mailto:info@alivamab.com\">info@alivamab.com<\/a><\/p>\n<h2>Get in Touch<\/h2>\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/shell.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n              region: \"na1\",\n              portalId: \"7228473\",\n              formId: \"75b2123b-0416-4548-a63b-9d3fe4d799ba\"\n});\n<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Company About Us AlivaMab Discovery Services (ADS) sets its partners\u2019 antibody discovery programs on the fastest and most de-risked path through discovery and development. Trusted by top-tier pharmaceutical and biotechnology companies, ADS delivers drug-quality, fully human antibodies on exceptional timelines. ADS achieves its partners\u2019 design goals, from simple to extraordinarily challenging, through the generation and [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-contact.php","meta":[],"_links":{"self":[{"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/pages\/10"}],"collection":[{"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/comments?post=10"}],"version-history":[{"count":20,"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/pages\/10\/revisions"}],"predecessor-version":[{"id":1227,"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/pages\/10\/revisions\/1227"}],"wp:attachment":[{"href":"https:\/\/alivamab.com\/dev\/wp-json\/wp\/v2\/media?parent=10"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}